WhiteSands Alcohol & Drug Rehab Publishes New Website Resource Examining How Long PCP Stays in the Body and Its Impact on Treatment Planning

WhiteSands Alcohol & Drug Rehab has published a new educational resource exploring how long phencyclidine, commonly known as ...

WhiteSands Alcohol & Drug Rehab Publishes New Website Resource Examining High-Functioning Alcoholism and Pathways to Treatment

Naples, Florida - April 07, 2026 - PRESSADVANTAGE - WhiteSands Alcohol & Drug Rehab has published a new educational ...

WhiteSands Alcohol & Drug Rehab Publishes New Website Resource Highlighting Patient Recovery Outcomes Through Outpatient Treatment Programs

WhiteSands Alcohol & Drug Rehab has published a new resource on its website examining a patient-reported recovery experience ...
Politifact

What’s driving down US overdose deaths? Experts cite drug supply changes, increased naloxone

Beginning in 2023, there was less fentanyl in the U.S. drug supply. The opioid-overdose reversing drug naloxone’s availability is increasing and so is access to addiction treatment. Experts say the ...
The New York Times

It Was a Promising Addiction Treatment. Many Patients Never Got It.

How political red tape and a drug company’s thirst for profits limited the reach of a drug that experts believe could have reduced the opioid epidemic’s toll. Credit...Photo illustration by Ben Denzer ...
Yahoo

Drug company ads are easy to blame for misleading patients and raising costs, but research shows they do help patients get needed treatment

Add Yahoo as a preferred source to see more of our stories on Google. The United States is one of just two countries where drugmakers can advertise directly to patients. BrianAJackson/iStock via Getty ...
mskcc.org

New Drug Treatment for Low-Grade Serous Ovarian Cancer (LGSOC), Sparked by Decade-Old Discovery

Ellen Coopersmith rows across the Lake in Central Park. Now that she is retired from her job as a kindergarten teacher, she enjoys spending extra time in New York City when she comes to MSK for her ...